SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
Siddappa N. Byrareddy, Mahesh Mohan
Topics & Concepts
MedicineInflammationRespiratory distressLungRespiratory systemCoronavirus disease 2019 (COVID-19)Acute respiratory distressImmunologyIntensive care medicineAnesthesiaInternal medicineDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 and Mental HealthCOVID-19 Clinical Research Studies